Alivus Life Sciences Ltd. | Mid-cap | Healthcare
₹998.20
-0.26%
| Alivus Life Sciences Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 21.8B
Gross Profit 11.6B 53.28%
Operating Income 6.2B 28.48%
Net Income 4.7B 21.55%
EPS (Diluted) ₹38.38

Balance Sheet Metrics

Total Assets 28.5B
Total Liabilities 5.2B
Shareholders Equity 23.3B
Debt to Equity 0.22

Cash Flow Metrics

Operating Cash Flow 4.7B
Free Cash Flow 2.8B

Revenue & Profitability Trend

Alivus Life Sciences Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 21.8B 20.5B 20.9B 18.6B 14.9B
Cost of Goods Sold 10.2B 10.3B 10.6B 9.2B 7.0B
Gross Profit 11.6B 10.2B 10.3B 9.5B 7.9B
Operating Expenses 2.5B 2.5B 2.2B 1.8B 1.8B
Operating Income 6.2B 6.0B 5.8B 5.6B 4.4B
Pre-tax Income 6.3B 6.3B 5.6B 4.7B 4.2B
Income Tax 1.6B 1.6B 1.5B 1.2B 1.1B
Net Income 4.7B 4.7B 4.2B 3.5B 3.1B
EPS (Diluted) ₹38.38 ₹38.11 ₹35.63 ₹28.69 ₹25.55

Income Statement Trend

Alivus Life Sciences Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 19.2B 18.5B 17.6B 14.0B 11.6B
Non-Current Assets 9.3B 8.5B 7.1B 6.0B 5.7B
Total Assets 28.5B 27.0B 24.7B 20.0B 17.3B
Liabilities
Current Liabilities 4.4B 5.0B 3.8B 12.2B 13.1B
Non-Current Liabilities 793.2M 674.0M 327.0M 228.9M 164.5M
Total Liabilities 5.2B 5.6B 4.2B 12.4B 13.2B
Equity
Total Shareholders Equity 23.3B 21.4B 20.5B 7.5B 4.0B

Balance Sheet Composition

Alivus Life Sciences Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 6.3B 6.3B 5.6B 4.7B 4.2B
Operating Cash Flow 4.7B 2.4B 7.0B 3.7B 2.4B
Investing Activities
Capital Expenditures -1.3B -1.6B -1.3B -663.6M -508.7M
Investing Cash Flow -1.3B -1.6B -1.3B -719.7M -508.7M
Financing Activities
Dividends Paid -2.8B -3.9B -1.3B - -
Financing Cash Flow -2.8B -3.9B -496.7M -4.3B -1.4B
Free Cash Flow 2.8B 1.4B 4.7B 3.2B 1.4B

Cash Flow Trend

Alivus Life Sciences Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 31.45
Forward P/E 22.31
Price to Book 5.23
Price to Sales 6.03
PEG Ratio 22.31

Profitability Ratios

Profit Margin 19.21%
Operating Margin 23.53%
Return on Equity 17.18%
Return on Assets 11.43%

Financial Health

Current Ratio 4.52
Debt to Equity 0.63
Beta 0.16

Per Share Data

EPS (TTM) ₹34.48
Book Value per Share ₹207.20
Revenue per Share ₹179.94

Financial data is updated regularly. All figures are in the company's reporting currency.